Evidence map›Paper›PMID 39649025›Full record

ArticleInternational journal of cardiology. Heart & vasculature2024

Impact of renin-angiotensin system targeted therapy on aortic elastic properties assessed by computed tomography.

Niya Mileva, Panayot Panayotov, Irina Hristova, Greta Koleva, Despina Georgieva, Raya Ivanova, Dobrin Vassilev

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Niya MilevaMedica Cor Hospital, 1713 Ruse, Bulgaria.
Panayot PanayotovMedica Cor Hospital, 1713 Ruse, Bulgaria.
Irina HristovaRuse University "Angel Kanchev", Ruse, Bulgaria.
Greta KolevaRuse University "Angel Kanchev", Ruse, Bulgaria.
Despina GeorgievaRuse University "Angel Kanchev", Ruse, Bulgaria.
Raya IvanovaMedical Faculty, Medical University of Sofia, 1431 Sofia, Bulgaria.
Dobrin VassilevMedica Cor Hospital, 1713 Ruse, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Aortic stiffening is a well-known cardiovascular risk factor. Computed tomography (CT) has proven to be a valuable tool in the assessment of aortic elastic properties. Drugs that inhibit the renin-angiotensin system (RAS) play a central role in cardioprotective therapy. We aimed to evaluate the relationship between aortic elastic properties and RAS-targeted therapy in hypertensive patients. Methods: This is an observational prospective study of hypertensive patients with nonobstructive coronary artery disease who underwent coronary CT angiography (CCTA). Aortic compliance and distensibility were calculated from the ECG-gated CCTA image. Patients were divided into two groups - those with RAS-targeted therapy - RAS(+) and those with non-RAS-targeted therapy - RAS(-). The elastic properties of the aorta were compared between the two groups. Results: A total of 142 patients were included in the final analysis. 53.5 % of the population were in the RAS(+) group and 46.5 % in the RAS(-) group. Elastic properties of ascending and descending aorta were significantly higher in the RAS(+) group compared to the RAS(-) group: AA compliance 1.42 ± 0.75 mm Conclusion: Patients receiving RAS-blocking treatment revealed significantly higher compliance and distensibility of ascending and descending aorta. In addition, aortic elastic properties were significantly correlated with the RAS-targeted therapy.

Indexed as

AortaComplianceDistensibilityHypertension

Identifiers

PMID39649025
PMCPMC11625146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.